Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 501 to 510

ROSUVASTATIN HX rosuvastatin (as calcium) 5 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROSUVASTATIN HX rosuvastatin (as calcium) 10 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROSUVASTATIN HX rosuvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROSUVASTATIN HX rosuvastatin (as calcium) 40 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
LAMOTRIGINE SANDOZ lamotrigine 25 mg dispersible/chewable tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIRTAZAPINE GH mirtazapine 30mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ESOMEPRAZOLE SANDOZ esomeprazole (as magnesium) 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
PROPOFOL HX propofol 1000mg/100mL emulsion for injection vial Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
CAPTOPRIL SANDOZ captopril 12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd
DILTIAZEM SANDOZ diltiazem hydrochloride 60mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 47
Page 48
Page 49
Page 50
Current page 51
Page 52
Page 53
Page 54
Page 55
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.